These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 39427014)
1. Impaired SARS-CoV-2-specific responses via activated T follicular helper cells in immunocompromised kidney transplant recipients. Tomita Y; Uehara S; Terada M; Yamamoto N; Nakamura M Sci Rep; 2024 Oct; 14(1):24571. PubMed ID: 39427014 [TBL] [Abstract][Full Text] [Related]
2. The Humoral Immune Response to BNT162b2 Vaccine Is Associated With Circulating CD19+ B Lymphocytes and the Naïve CD45RA to Memory CD45RO CD4+ T Helper Cells Ratio in Hemodialysis Patients and Kidney Transplant Recipients. Duni A; Markopoulos GS; Mallioras I; Pappas H; Pappas E; Koutlas V; Tzalavra E; Baxevanos G; Priska S; Gartzonika K; Mitsis M; Dounousi E Front Immunol; 2021; 12():760249. PubMed ID: 34925330 [TBL] [Abstract][Full Text] [Related]
8. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech). Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063 [TBL] [Abstract][Full Text] [Related]
9. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial. Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302 [TBL] [Abstract][Full Text] [Related]
10. Inter- and intra-individual differences regarding SARS-CoV-2 and influenza vaccination in pediatric kidney transplant recipients: An observational study. Kanai T; Ito T; Saito T; Aoyagi J; Kurosaki M; Betsui H; Maru T; Ono M; Tajima T Medicine (Baltimore); 2024 Jul; 103(27):e38809. PubMed ID: 38968522 [TBL] [Abstract][Full Text] [Related]
11. Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients. Bertrand D; Hamzaoui M; Lemée V; Lamulle J; Hanoy M; Laurent C; Lebourg L; Etienne I; Lemoine M; Le Roy F; Nezam D; Plantier JC; Boyer O; Guerrot D; Candon S J Am Soc Nephrol; 2021 Sep; 32(9):2147-2152. PubMed ID: 34112706 [TBL] [Abstract][Full Text] [Related]
12. Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients. Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N Front Immunol; 2022; 13():1050211. PubMed ID: 36532067 [TBL] [Abstract][Full Text] [Related]
13. Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination. De Bouver C; Bouziotis J; Wijtvliet VPWM; Ariën KK; Mariën J; Heyndrickx L; Couttenye MM; de Fijter HJW; Mestrez F; Treille S; Mat O; Collart F; Allard SD; Vingerhoets L; Moons P; Abramowicz D; De Winter BY; Pipeleers L; Wissing KM; Ledeganck KJ Virol J; 2024 Jun; 21(1):138. PubMed ID: 38872127 [TBL] [Abstract][Full Text] [Related]
14. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children. Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243 [TBL] [Abstract][Full Text] [Related]
15. A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS-CoV-2 mRNA vaccine. Borgogna C; Ferrante D; Rosso G; Guglielmetti G; Lo Cigno I; Raviola S; Caneparo V; Quaglia M; Cantaluppi V; Gariglio M J Med Virol; 2024 Jun; 96(6):e29710. PubMed ID: 38804187 [TBL] [Abstract][Full Text] [Related]
16. Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients. Zhang L; Yang J; Lai C; Wan L; Xiong S; Kong W; Liu Z; Yu P; Chen M; Mai W; Khan SA; Deng M; Chen L; Lei Y; Zhou Q; Yu N; Li P; Chen Z; Ji T Front Immunol; 2022; 13():1042784. PubMed ID: 36700230 [TBL] [Abstract][Full Text] [Related]
17. Detectable plasma severe acute respiratory syndrome coronavirus 2 spike antigen is associated with poor antibody response following third messenger RNA vaccination in kidney transplant recipients. Karaba AH; Swank Z; Hussain S; Chahoud M; Durand CM; Segev DL; Robien MA; Heeger PS; Larsen CP; Tobian AAR; Walt DR; Werbel WA Transpl Infect Dis; 2024 Jun; 26(3):e14281. PubMed ID: 38618895 [TBL] [Abstract][Full Text] [Related]
18. Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients. Capone M; Vanni A; Salvati L; Lamacchia G; Mazzoni A; Maggi L; Cosmi L; Liotta F; Romagnani P; Cirillo L; Buti E; Terlizzi V; Azzari C; Citera F; Barbati F; Rossolini GM; Bresci S; Borchi B; Cavallo A; Mencarini J; Francalanci E; Kiros ST; Bartoloni A; Annunziato F Immunol Lett; 2024 Aug; 268():106886. PubMed ID: 38906482 [TBL] [Abstract][Full Text] [Related]
19. mRNA-based COVID-19 vaccination of lung transplant recipients with prior SARS-CoV-2 infection induces durable SARS-CoV-2-specific antibodies and T cells. Liu S; van Dijk LLA; den Hartog Y; Hoek R; Verschuuren E; Geurtsvankessel CH; de Vries RD; Van Baarle D; Buter CVL Vaccine; 2024 Oct; 42(24):126250. PubMed ID: 39226789 [TBL] [Abstract][Full Text] [Related]